The metabolism of pyrimidines by proteolytic clostridia.
Uracil was used by growing cultures of Clostridium sporogenes, and by proteolytic strains of C. botulinum types A and B. Uracil was not used by C. bifermentans; C. botulinum, type B (non-proteolytic); C. botulinum, type F (non-proteolytic); C. botulinum, type E; C. butyricum; C. cochlearium; C. difficile; C. histolyticum; C. oedematiens, type A; C. paraputrificum; C. scatologenes; C. specticum; C. sordellii; C. sticklandii; C. tertium; C. tetani; C. tetanomorphum; C. welchii, types A, B, C, E and 4 untyped strains. The growth of C. sporogenes was not increased by uracil; it was reduced to dihydrouracil. Experiments with washed cells of C. sporogenes showed that the uracil-reducing system was inducible. Washed cell suspensions incubated under hydrogen with uracil, thymine, iso-barbituric acid, 5-amino uracil and cytosine consumed 1 mole H2/mole pyrimidine. The reduction product of cytosine was dihydrouracil indicating that it was deaminated before reduction. The reduction products of the  remaining pyrimidines were the corresponding dihydro derivatives. Extracts of C. sporogenes reduced uracil in the presence of NADPH2 but not NADH2.
D001463:Barbiturates / Q000031:analogs & derivatives; D003013:Clostridium / Q000378:metabolism*; D003014:Clostridium botulinum / Q000378:metabolism; D003017:Clostridium tetani / Q000378:metabolism; D003470:Culture Media; D003596:Cytosine; D005285:Fermentation; D006859:Hydrogen; D009243:NAD; D009249:NADP; D010084:Oxidation-Reduction; D011743:Pyrimidines / Q000378:metabolism*; D013941:Thymine; D014498:Uracil / Q000031:analogs & derivatives / Q000378:metabolism*
D001463:Barbiturates; D003470:Culture Media; D011743:Pyrimidines; D009243:NAD; D009249:NADP; D014498:Uracil; D006859:Hydrogen; D003596:Cytosine; D013941:Thymine